ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Proqr Therapeutics (PRQR) Technical (Analysis) Reports Proqr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Proqr Therapeutics (PRQR)

Technical Analysis Report for NASDAQ stock PRQR Proqr Therapeutics. Dated: 14 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PRQR Proqr Therapeutics then click here. or read Experts views on Proqr Therapeutics or Forecast & share price targets of Proqr Therapeutics

Proqr Therapeutics Opened at 1.70 and Closed at: 1.65, which is -3.03% of previous session's close. It moved within a range of 1.62 and 1.73
The session was a Bearish session with an average volume of 360200, which is -73.79% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.

A Golden cross was found 1 days back on short term averages

Support for tomorrow is 1.58 and resistance for tomorrow is 1.69
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.6, 1.56 resistance for tomorrow's hourly charts is 1.71, 1.78

10 Day SMA for Proqr Therapeutics (PRQR) is 1.64 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Proqr Therapeutics (PRQR) is 1.63 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Proqr Therapeutics (PRQR) is 1.69 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 1.69 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Proqr Therapeutics is 1.99 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Proqr Therapeutics is at 1.63 and 200 DMA is at 1.99, while 50 DMA and 100 DMA are at 1.69 and 1.69 respectively

Proqr Therapeutics (PRQR) moving average of 20 SMA is at 1.63 and 20 EMA is at 1.65

Proqr Therapeutics (PRQR) moving average of 50 SMA is at 1.69 and 50 EMA is at 1.67

Proqr Therapeutics (PRQR) moving average of 100 SMA is at 1.69 and 100 EMA is at 1.77

Proqr Therapeutics (PRQR) moving average of 200 SMA is at 1.99 and 200 EMA is at 1.98

Vtv Therapeutics has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Vtv Therapeutics, about 12.13% more returns!

Surgery Partners has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Surgery Partners, about 11.52% more returns!

Regeneron Pharmaceuticals has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Regeneron Pharmaceuticals, about 5.45% more returns!

Proqr Therapeutics has performed better than Phio Pharmaceuticals in short term. Holding Proqr Therapeutics could be a better choice for now!

Proqr Therapeutics has performed better than Merit Medical in short term. Holding Proqr Therapeutics could be a better choice for now!

Atyr Pharma has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Atyr Pharma, about 50.77% more returns!

Proqr Therapeutics has performed better than Adial Pharmaceuticals in short term. Holding Proqr Therapeutics could be a better choice for now!

Proqr Therapeutics has performed better than Alector Inc in short term. Holding Proqr Therapeutics could be a better choice for now!

Alkermes Plc has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Alkermes Plc, about 22.4% more returns!

Amarin Corporation has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Amarin Corporation, about 11.42% more returns!

Apyx Medical has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 20.99% more returns!

Axsome Therapeutics has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 33.43% more returns!

Esperion Therapeutics has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Esperion Therapeutics, about 64.79% more returns!

Henry Schein has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 2.07% more returns!

Innoviva Inc has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Innoviva Inc, about 5.9% more returns!

Apellis Pharmaceuticals has performed better than Proqr Therapeutics in short term. You could have earned much better returns by investing in Apellis Pharmaceuticals, about 10.65% more returns!

Proqr Therapeutics Technical analysis of indicators

Price action analysis of Proqr Therapeutics (PRQR) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Proqr Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Proqr Therapeutics in short term and the sell signal is strong.

Proqr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Proqr Therapeutics in short term

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Proqr Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.64 and Proqr Therapeutics PRQR stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Proqr Therapeutics PRQR stock. Volume based technical analysis of Proqr Therapeutics PRQR stock is negative.

Proqr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock PRQR Proqr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And PRQR Experts View which covers a lot of information including buying and selling signals

PRQR future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Proqr Therapeutics or View Candle Stick Charts here

Chart Proqr Therapeutics (PRQR)  Technical (Analysis) Reports Proqr Therapeutics [

Videos related to: Proqr Therapeutics (PRQR) Technical (Analysis) Reports Proqr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Proqr Therapeutics (PRQR)  Technical (Analysis) Reports Proqr Therapeutics [

 

Back to top